Titre:
  • Final results of a clinical and pharmacokinetic (PK) phase I study of the Raf kinase inhibitor BAY 43-9006 in refractory solid cancers: A promising anti-tumor agent
Auteur:Awada, Ahmad; Hendlisz, Alain; Gil, Thierry; Munoz Bermeo, René Arturo; Bartholomeus, Sylvie; de Valeriola, Dominique; van der Auwera, Johan; Coppieters, S.; Moeller, J.G.; Piccart-Gebhart, Martine
Informations sur la publication:(2002), European Journal of Cancer, Vol. 38, page (52)
Statut de publication:Publié, 2002
series:S, 162
Sujet CREF:Cancérologie
Pharmacologie
Langue:Anglais